Annovis Bio, Inc.ANVSNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-48.45%
↓ 133% below average
Average (7y)
148.58%
Historical baseline
Range
High:595.52%
Low:-59.17%
Volatility
440.6%
High variability
| Period | Value |
|---|---|
| 2024 | -48.45% |
| 2023 | 134.88% |
| 2022 | 94.78% |
| 2021 | 177.63% |
| 2020 | 293.43% |
| 2019 | 595.52% |
| 2018 | -59.17% |
| 2017 | 0.00% |